Drugs / NM404
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00582283 | Jan 2004 → Aug 2014 | non-small cell lung carcinoma | University of Wisconsin, Madison | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01540513 | Mar 2012 → Oct 2014 | glioblastoma, metastatic malignant neoplasm in the brain | University of Wisconsin, Madison | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NM404 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00582283 ↗ |
| Modality | Diagnostic / imaging agent | “NM404 as an Imaging Agent in Patients With NSCLC” NCT00582283 ↗ |